Sanofi

We’re an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth.

Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

11/05/2026

🏁 When racing becomes personal…

For Mikkel Jensen, diabetes isn't just something he cares about, it's part of his family story.

With Sanofi and United Autosports, the 2026 24 Hours of Le Mans takes on an even deeper meaning. Like endurance racing, living with diabetes is all about constant decisions, resilience, and the support around you every step of the way. On the track and in life, no one competes alone. 🏎️💙

24 Heures du Mans International Diabetes Federation

06/05/2026

🏁 Back on track for a second consecutive year with United Autosports at the 2026 24 Heures du Mans!
Ready to push things further.
When speed meets science, extraordinary things happen.
The race continues... 🏎️💙
Stay tuned for what's coming next 👀
McLaren

17/04/2026

This , we’re deeply moved by Megan Adediran, Founder of the Haemophilia Foundation of Nigeria, and a mother to two sons with Haemophilia A. Her journey began with a personal fight to save her sons.

Megan’s advocacy highlights why “Diagnosis, first step to care” is so vital. In Nigeria, despite an estimated 11,000 people living with haemophilia, only about 1,000 are diagnosed, a gap due to major barriers like access to medical care and disease education.

Sanofi is proud to stand with leaders like Megan. Our commitment, in partnership with the World Federation of Hemophilia (WFH), focuses on ensuring equitable access to diagnosis and sustainable care globally.

Learn more about Sanofi’s global efforts in hemophilia care: http://spkl.io/6188A4PAn

09/04/2026

Jokainen läpimurto alkaa sinnikkyydestä.
Erityisesti alalla, jolla jopa 99 % ideoista ei koskaan etene hoitomuodoksi. M***a se yksi prosentti, joka onnistuu, voi muuttaa sairastuneiden elämän.

Tätä työtä tekee Nadine, Sanofin immunologiatutkimuksen Cluster Head. Hänellä on vahva halu vaikuttaa ihmisten elämään. Tiimeineen hän tutkii, miksi jokin hoito toimii joillekin muttei toisille, ja kääntää tieteen todelliseksi, ihmisten arjessaan kokemaksi muutokseksi.

Edistys terveydenhuollossa ei tapahdu yhdessä yössä. Se vaatii intohimoa ja sitoutumista. Silti juuri läpimurron hetki pitää unelman elossa.

👉 Lue Nadinen tarina: http://spkl.io/6187AFXaD

09/04/2026

Ethvert gennembrud begynder med vedholdenhed.

Især i et felt, hvor helt op til 99 % af alle idéer aldrig når i mål. Men den ene procent, der gør, har potentialet til at ændre patienters liv. Det er præcis dét, Nadine, Cluster Head for Immunology Research hos Sanofi, arbejder utrætteligt for.

Drevet af ønsket om at gøre en reel forskel undersøger hun og hendes team, hvorfor behandlinger virker for nogle patienter – men ikke for andre. De omsætter kompleks videnskab til konkrete fremskridt, der kan mærkes i hverdagen for mennesker, som lever med alvorlige sygdomme.

Fremskridt i sundhed sker sjældent fra dag til dag. Men passionen, nysgerrigheden og troen på, at det kan lykkes, flytter grænserne lidt hver eneste dag.

👉 Læs hele Nadines historie her: http://spkl.io/6188AFXvY

09/04/2026

Alla genombrott börjar med ihärdighet.

Särskilt inom ett område där upp till 99 % av idéerna inte leder hela vägen, men där den procent som faktiskt når fram kan förändra liv. Det är detta Nadine, Cluster Head for Immunology Research på Sanofi, arbetar för att uppnå.

Viljan att göra skillnad och förstå varför behandlingar fungerar för vissa personer, men inte för andra, driver Nadine och hennes team framåt – och de omvandlar vetenskap till faktisk patientnytta.

Framsteg kräver passion och engagemang över tid, och genombrotten driver arbetet framåt!

👉 Läs mer om Nadines historia här https://www.sanofi.com/en/chasing-miracles/people-stories/nadine-story-research-development-sanofi-germany

09/04/2026

Ethvert gjennombrudd begynner med utholdenhet. Særlig i et felt der helt opp til 99 % av alle idéer aldri når i mål. Men den ene prosenten som gjør det, har potensialet til å endre pasienters liv. Det er nettopp det Nadine, Cluster Head for Immunology Research hos Sanofi, jobber utrettelig for.

Drevet av ønsket om å gjøre en reell forskjell undersøker hun og teamet hennes hvorfor behandlinger virker for noen pasienter – men ikke for andre. De omsetter kompleks vitenskap til konkrete fremskritt som kan merkes i hverdagen for mennesker som lever med alvorlige sykdommer.

Fremskritt innen helse skjer sjelden fra dag til dag. Men lidenskapen, nysgjerrigheten og troen på at det kan lykkes, flytter grensene litt for hver eneste dag.

👉 Les hele Nadines historie her: http://spkl.io/6188AFXQm

31/03/2026

We are proud to announce our strategic partnership with Station F, the world's largest startup campus. As the first biopharma company to launch such a comprehensive program, this unique collaboration is aimed at accelerating AI-powered R&D and leading the development of a groundbreaking "digital immune system."

We're inviting innovative, early-stage health-tech and biotech startups from around the globe to join us. This is an opportunity to gain access to Sanofi's scientific expertise, proprietary data, and mentorship, combining your fresh entrepreneurial energy with our mission to unlock new breakthroughs for patients worldwide.

Are you a founder or innovator ready to make a real impact? True transformation happens together. Learn more and submit your application today: http://spkl.io/6189AFWHX

30/03/2026

🎬 What if you could see where the miracles of science become reality?

From breakthroughs in the lab to innovation in manufacturing.

We open the doors of Modulus, Sanofi’s factory of the future.

Watch episode 1 of our documentary series Making It Real now: https://www.youtube.com/watch?v=cGft-_FtrAo

26/03/2026

“If I get out of this, I will help everyone who has this disease.”

When Géraldine was diagnosed with COPD, she made herself a promise. Today, she’s keeping it. 💜

Now thriving in respiratory rehab, Géraldine is inspiring others facing the same challenges, proving that life can be rebuilt, breath by breath, step by step.

Her hope? A future where scientific breakthroughs help people with COPD. Stories like Géraldine’s remind us why we never stop chasing the miracles of sciences.

Learn how Géraldine is making a difference and helping others in the COPD community: http://spkl.io/6180A0QZj

24/03/2026

🎬 Science doesn’t become medicine by magic.

Every day, our teams, technologies, and industrial innovation turn the miracles of science into reality for patients.

Making It Real steps inside Sanofi M&S, an immersive journey where scientific breakthroughs come to life. Behind every vaccine and medicine is a patient counting on us.

Episode 1 premieres March 30. Watch the teaser now and discover the hidden world innovation meets impact.

Adresse

46 Avenue De La Grande Armée
Paris
75017

Site Web

https://www.sanofi.com/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Sanofi publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.